title: Sulodexide versus calcium heparin in the medium-term treatment of deep vein thrombosis of the lower limbs.
abstract: Thirty adult patients with distal, monolateral deep vein thrombosis of the lower limbs were randomly treated for sixty days either with subcutaneous Ca-Heparin or with Sulodexide, administered IM for ten days and orally for fifty days. The thrombus accretion above the knee, the venous pressures of the affected leg, the clinical symptomatology, and some laboratory coagulative tests were monitored throughout the administration period. Local tolerability of the two treatments was also evaluated. The two applied treatments evidenced a net antithrombotic activity, preventing thrombus accretion above the knee, improving with the same efficacy the venous pressures in the affected legs, and similarly reducing clinical symptoms, with a quick and statistically significant trend toward normalization. Blood fibrinogen was significantly lowered by both drugs, while only Ca-heparin yielded a prolongation of activated partial thromboplastin time. Local tolerability of treatments was better for the mainly oral Sulodexide administrations, while subcutaneous Ca-heparin often induced small, though transient, hematomas.
authors.affiliation: Institute of Internal Medicine, University of Palermo, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Pinto
authors.forename: S
authors.initials: S
authors.lastname: Corrao
authors.forename: D
authors.initials: D
authors.lastname: Galati
authors.forename: S
authors.initials: S
authors.lastname: Arnone
authors.forename: A
authors.initials: A
authors.lastname: Licata
authors.forename: G
authors.initials: G
authors.lastname: Parrinello
authors.forename: T
authors.initials: T
authors.lastname: Maniscalchi
authors.forename: G
authors.initials: G
authors.lastname: Licata
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006025:Glycosaminoglycans / Q000008:administration & dosage / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013924:Thrombophlebitis / Q000188:drug therapy*
chemical_list: D005343:Fibrinolytic Agents; D006025:Glycosaminoglycans; C006871:calcium heparin; C007858:glucuronyl glucosamine glycan sulfate; D006493:Heparin